{"id":"https://openalex.org/W2343131997","doi":"https://doi.org/10.1111/dom.12681","title":"Effects of obeticholic acid on lipoprotein metabolism in healthy volunteers","display_name":"Effects of obeticholic acid on lipoprotein metabolism in healthy volunteers","alternate_titles":[],"publication_year":2016,"publication_date":"2016-06-06","ids":{"openalex":"https://openalex.org/W2343131997","doi":"https://doi.org/10.1111/dom.12681","mag":"2343131997","pmid":"https://pubmed.ncbi.nlm.nih.gov/27109453"},"language":"en","primary_location":{"id":"doi:10.1111/dom.12681","doi":"https://doi.org/10.1111/dom.12681","is_oa":false,"landing_page_url":"https://doi.org/10.1111/dom.12681","pdf_url":null,"source":{"id":"https://openalex.org/S148394532","display_name":"Diabetes Obesity and Metabolism","issn_l":"1462-8902","issn":["1462-8902","1463-1326"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, Obesity and Metabolism","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2343131997"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5039393797","display_name":"Richard Pencek","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I55878746","display_name":"Intercept Pharmaceuticals (United States)","ror":"https://ror.org/01sx6jc36","country_code":"US","type":"company","lineage":["https://openalex.org/I55878746"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"R. Pencek","raw_affiliation_strings":["Intercept Pharmaceuticals, Inc., San Diego, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Intercept Pharmaceuticals, Inc., San Diego, CA, USA","institution_ids":["https://openalex.org/I55878746"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042490892","display_name":"Tonya Marmon","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I55878746","display_name":"Intercept Pharmaceuticals (United States)","ror":"https://ror.org/01sx6jc36","country_code":"US","type":"company","lineage":["https://openalex.org/I55878746"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"T. Marmon","raw_affiliation_strings":["Intercept Pharmaceuticals, Inc., San Diego, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Intercept Pharmaceuticals, Inc., San Diego, CA, USA","institution_ids":["https://openalex.org/I55878746"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086331303","display_name":"Jonathan David Roth","orcid":"https://orcid.org/0000-0002-1983-385X","observed_orcids":["https://orcid.org/0000-0002-1983-385X"]},"institutions":[{"id":"https://openalex.org/I55878746","display_name":"Intercept Pharmaceuticals (United States)","ror":"https://ror.org/01sx6jc36","country_code":"US","type":"company","lineage":["https://openalex.org/I55878746"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"J. D. Roth","raw_affiliation_strings":["Intercept Pharmaceuticals, Inc., San Diego, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Intercept Pharmaceuticals, Inc., San Diego, CA, USA","institution_ids":["https://openalex.org/I55878746"]}]},{"author_position":"middle","author":{"id":null,"display_name":"A. Liberman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I55878746","display_name":"Intercept Pharmaceuticals (United States)","ror":"https://ror.org/01sx6jc36","country_code":"US","type":"company","lineage":["https://openalex.org/I55878746"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"A. Liberman","raw_affiliation_strings":["Intercept Pharmaceuticals, Inc., San Diego, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Intercept Pharmaceuticals, Inc., San Diego, CA, USA","institution_ids":["https://openalex.org/I55878746"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050425208","display_name":"Roya Hooshmand-Rad","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I55878746","display_name":"Intercept Pharmaceuticals (United States)","ror":"https://ror.org/01sx6jc36","country_code":"US","type":"company","lineage":["https://openalex.org/I55878746"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"R. Hooshmand\u2010Rad","raw_affiliation_strings":["Intercept Pharmaceuticals, Inc., San Diego, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Intercept Pharmaceuticals, Inc., San Diego, CA, USA","institution_ids":["https://openalex.org/I55878746"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5101439791","display_name":"Mark A. Young","orcid":"https://orcid.org/0000-0001-5442-750X","observed_orcids":["https://orcid.org/0000-0001-5442-750X"]},"institutions":[{"id":"https://openalex.org/I55878746","display_name":"Intercept Pharmaceuticals (United States)","ror":"https://ror.org/01sx6jc36","country_code":"US","type":"company","lineage":["https://openalex.org/I55878746"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"M. A. Young","raw_affiliation_strings":["Intercept Pharmaceuticals, Inc., San Diego, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Intercept Pharmaceuticals, Inc., San Diego, CA, USA","institution_ids":["https://openalex.org/I55878746"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5101439791"],"corresponding_institution_ids":["https://openalex.org/I55878746"],"apc_list":{"value":5380,"currency":"USD","value_usd":5380},"apc_paid":null,"fwci":3.2468,"has_fulltext":false,"cited_by_count":70,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.92544535,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":87,"max":99},"biblio":{"volume":"18","issue":"9","first_page":"936","last_page":"940"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11618","display_name":"Cholesterol and Lipid Metabolism","score":0.82669997215271,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11618","display_name":"Cholesterol and Lipid Metabolism","score":0.82669997215271,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":0.0812000036239624,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13430","display_name":"Lipid metabolism and disorders","score":0.028699999675154686,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/obeticholic-acid","display_name":"obeticholic acid","score":1.0},{"id":"https://openalex.org/keywords/farnesoid-x-receptor-agonist","display_name":"farnesoid X receptor agonist","score":0.9440000057220459},{"id":"https://openalex.org/keywords/bile-acid-analogues","display_name":"bile acid analogues","score":0.7710000276565552},{"id":"https://openalex.org/keywords/lipoprotein-metabolism","display_name":"lipoprotein metabolism","score":0.9919999837875366},{"id":"https://openalex.org/keywords/cholesterol-metabolism","display_name":"cholesterol metabolism","score":0.6769999861717224},{"id":"https://openalex.org/keywords/hdl-cholesterol","display_name":"HDL cholesterol","score":0.984000027179718},{"id":"https://openalex.org/keywords/ldl-cholesterol","display_name":"LDL cholesterol","score":0.9950000047683716},{"id":"https://openalex.org/keywords/hdl-particle-size","display_name":"HDL particle size","score":0.7940000295639038},{"id":"https://openalex.org/keywords/ldl-particle-size","display_name":"LDL particle size","score":0.9649999737739563},{"id":"https://openalex.org/keywords/non-alcoholic-fatty-liver-disease","display_name":"non-alcoholic fatty liver disease","score":0.8090000152587891},{"id":"https://openalex.org/keywords/non-alcoholic-steatohepatitis","display_name":"nonalcoholic steatohepatitis","score":0.9490000009536743},{"id":"https://openalex.org/keywords/healthy-volunteers","display_name":"healthy volunteers","score":0.5770000219345093}],"concepts":[{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.734486997127533},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.7243109345436096},{"id":"https://openalex.org/C203862802","wikidata":"https://www.wikidata.org/wiki/Q14905041","display_name":"Farnesoid X receptor","level":5,"score":0.6877831816673279},{"id":"https://openalex.org/C2777067796","wikidata":"https://www.wikidata.org/wiki/Q15708271","display_name":"Obeticholic acid","level":4,"score":0.6683228015899658},{"id":"https://openalex.org/C2778163477","wikidata":"https://www.wikidata.org/wiki/Q43656","display_name":"Cholesterol","level":2,"score":0.6136965155601501},{"id":"https://openalex.org/C2780072125","wikidata":"https://www.wikidata.org/wiki/Q28350","display_name":"Lipoprotein","level":3,"score":0.5880087018013},{"id":"https://openalex.org/C2911022245","wikidata":"https://www.wikidata.org/wiki/Q28350","display_name":"Lipoprotein particle","level":5,"score":0.540732741355896},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4746575653553009},{"id":"https://openalex.org/C167400880","wikidata":"https://www.wikidata.org/wiki/Q3454539","display_name":"Liver X receptor","level":5,"score":0.4581242799758911},{"id":"https://openalex.org/C2779478299","wikidata":"https://www.wikidata.org/wiki/Q2335423","display_name":"Steatohepatitis","level":4,"score":0.4376991093158722},{"id":"https://openalex.org/C2778772119","wikidata":"https://www.wikidata.org/wiki/Q6058862","display_name":"Fatty liver","level":3,"score":0.42495444416999817},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.41579392552375793},{"id":"https://openalex.org/C4733338","wikidata":"https://www.wikidata.org/wiki/Q2792936","display_name":"Lipid metabolism","level":2,"score":0.410376638174057},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.24056404829025269},{"id":"https://openalex.org/C63932345","wikidata":"https://www.wikidata.org/wiki/Q422500","display_name":"Nuclear receptor","level":4,"score":0.21909266710281372},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.21351099014282227},{"id":"https://openalex.org/C8243546","wikidata":"https://www.wikidata.org/wiki/Q419074","display_name":"Very low-density lipoprotein","level":4,"score":0.1719343364238739},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.1443435251712799},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.06802541017532349},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0},{"id":"https://openalex.org/C86339819","wikidata":"https://www.wikidata.org/wiki/Q407384","display_name":"Transcription factor","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D000099150","descriptor_name":"Receptor, Farnesoid X-Activated","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001055","descriptor_name":"Apolipoproteins B","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D001055","descriptor_name":"Apolipoproteins B","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D002635","descriptor_name":"Chenodeoxycholic Acid","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D002635","descriptor_name":"Chenodeoxycholic Acid","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D002635","descriptor_name":"Chenodeoxycholic Acid","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008074","descriptor_name":"Lipoproteins","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D008074","descriptor_name":"Lipoproteins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D008076","descriptor_name":"Cholesterol, HDL","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D008076","descriptor_name":"Cholesterol, HDL","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D008078","descriptor_name":"Cholesterol, LDL","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D008078","descriptor_name":"Cholesterol, LDL","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009682","descriptor_name":"Magnetic Resonance Spectroscopy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014280","descriptor_name":"Triglycerides","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D015243","descriptor_name":"Cholesterol, VLDL","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D015243","descriptor_name":"Cholesterol, VLDL","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D016632","descriptor_name":"Apolipoprotein A-I","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D016632","descriptor_name":"Apolipoprotein A-I","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D018160","descriptor_name":"Receptors, Cytoplasmic and Nuclear","qualifier_ui":"Q000819","qualifier_name":"agonists","is_major_topic":true},{"descriptor_ui":"D064368","descriptor_name":"Healthy Volunteers","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1111/dom.12681","doi":"https://doi.org/10.1111/dom.12681","is_oa":false,"landing_page_url":"https://doi.org/10.1111/dom.12681","pdf_url":null,"source":{"id":"https://openalex.org/S148394532","display_name":"Diabetes Obesity and Metabolism","issn_l":"1462-8902","issn":["1462-8902","1463-1326"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, Obesity and Metabolism","raw_type":"journal-article"},{"id":"pmid:27109453","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/27109453","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, obesity & metabolism","raw_type":"Clinical Trial, Phase I"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.98580002784729,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":16,"referenced_works":["https://openalex.org/W1927556662","https://openalex.org/W1984875752","https://openalex.org/W1995076942","https://openalex.org/W1999547106","https://openalex.org/W2023512757","https://openalex.org/W2041166090","https://openalex.org/W2045054080","https://openalex.org/W2089526803","https://openalex.org/W2106768039","https://openalex.org/W2109429564","https://openalex.org/W2122860085","https://openalex.org/W2125109896","https://openalex.org/W2132302780","https://openalex.org/W2158609797","https://openalex.org/W2530844910","https://openalex.org/W4249387963"],"related_works":["https://openalex.org/W2980805882","https://openalex.org/W2560376329","https://openalex.org/W2793339107","https://openalex.org/W4403933880","https://openalex.org/W4224132696","https://openalex.org/W2673358573","https://openalex.org/W4322741348","https://openalex.org/W3091903120","https://openalex.org/W2122860085","https://openalex.org/W4387653862"],"abstract_inverted_index":{"The":[0,29],"bile":[1],"acid":[2,5],"analogue":[3],"obeticholic":[4],"(OCA)":[6],"is":[7],"a":[8,130,133],"selective":[9],"farnesoid":[10],"X":[11],"receptor":[12],"(FXR)":[13],"agonist":[14],"in":[15,38,75,80,88,104,135,149,154,160,172],"development":[16],"for":[17],"treatment":[18],"of":[19,31,53,57,72,95,110,123,132,146],"several":[20],"chronic":[21],"liver":[22,179],"diseases.":[23],"FXR":[24],"activation":[25],"regulates":[26],"lipoprotein":[27,36,155],"homeostasis.":[28],"effects":[30,52],"OCA":[32,63,101,114,159,175],"on":[33,64],"cholesterol":[34,84,106,117],"and":[35,82,98,107,112,118,137],"metabolism":[37,156],"healthy":[39,77,161],"individuals":[40,162],"were":[41,47,86,163],"assessed.":[42],"Two":[43],"phase":[44],"I":[45],"studies":[46],"conducted":[48],"to":[49,90,158,165],"evaluate":[50],"the":[51],"repeated":[54],"oral":[55],"doses":[56],"5,":[58],"10":[59],"or":[60,69,181],"25":[61],"mg":[62],"lipid":[65],"variables":[66],"after":[67],"14":[68],"20":[70],"days":[71],"consecutive":[73],"administration":[74],"68":[76],"adults.":[78],"Changes":[79,153],"HDL":[81,116,125],"LDL":[83,111,120,141,151],"levels":[85],"examined,":[87],"addition":[89],"nuclear":[91],"magnetic":[92],"resonance":[93],"analysis":[94],"particle":[96,108,126,142],"sizes":[97],"sub-fraction":[99],"concentrations.":[100],"elicited":[102],"changes":[103,171],"circulating":[105],"size":[109],"HDL.":[113,139],"decreased":[115],"increased":[119,144],"cholesterol,":[121],"independently":[122],"dose.":[124],"concentrations":[127,143],"declined":[128],"as":[129],"result":[131],"reduction":[134],"medium":[136],"small":[138],"Total":[140],"because":[145],"an":[147],"increase":[148],"large":[150],"particles.":[152],"attributable":[157],"found":[164],"be":[166],"consistent":[167],"with":[168,176],"previously":[169],"reported":[170],"patients":[173],"receiving":[174],"non-alcoholic":[177,182],"fatty":[178],"disease":[180],"steatohepatitis.":[183]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2343131997","counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":5},{"year":2022,"cited_by_count":10},{"year":2021,"cited_by_count":14},{"year":2020,"cited_by_count":11},{"year":2019,"cited_by_count":5},{"year":2018,"cited_by_count":8},{"year":2017,"cited_by_count":9},{"year":2016,"cited_by_count":3}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
